Expanding Beyond the Horizon: MarketsandMarkets Forecasting and Analytics Services to Help Pharmaceuticals Companies Tap Opportunities in Emerging Markets

DALLAS, April 28, 2010 - The pharmaceutical industry across the globe is currently facing a number
of challenges, including non-productive pipelines, stringent regulatory
pathways, threat from generic drugs, and cost containment pressure from the
governments in developed markets. However, emerging markets such as the BRIC
economies (Brazil, Russia, India, and China) offer pharma companies a
valuable opportunity as these nations are exhibiting strong economic growth,
rapidly growing per capita income, and increasing government spending on
healthcare.

To know more about our Pharmaceutical Forecasting services click here

www.marketsandmarkets.com/patient-based-forecasting.asp

This opportunity requires pharma companies to correctly identify,
estimate, and forecast the potential of various disease/therapeutic areas,
molecules, and brands in different geographies so as to devise
region-specific growth strategies. The right understanding of the market
dynamics, trends, and potential would help pharma companies make informed
decisions and plans on growth strategies, resource allocation, and on
launching right products at the right time in the right market.

About MarketsandMarkets

M&M has developed a center of excellence dedicated to address forecasting
and analytics needs of pharma companies seeking to enter emerging markets.
Forecasting pharma markets, molecules, and brands in emerging markets is
significantly different from forecasting developed markets such as U.S.,
Europe, and Japan, in terms of healthcare systems, product affordability and
consumer willingness to pay, the healthcare delivery, financing and
reimbursement mechanism, and the role of physicians, pharmacists, patients,
and the private sector. Thus, a detailed understanding of each element is
required to develop customized forecasting solutions. M&M's dedicated team of
analysts offer in-depth understanding on epidemiology, patients base,
analogues for forecasting analytics, and market dynamics specific to emerging
markets.

    Contact

    MarketsandMarkets
    Navrose Singh Sandhu
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    T: +1-888-989-8004
    Email: Navrose@marketsandmarkets.com

    www.marketsandmarkets.com

Contact: MarketsandMarkets, Navrose Singh Sandhu, 7557 Rambler road, Suite 727, Dallas, TX 75231, T: +1-888-989-8004, Email: Navrose at marketsandmarkets.com